Myalept is a drug that contains an artificial form of leptin, a hormone produced by fat cells and that acts on the nervous system regulating the feeling of hunger and metabolism, so it is used to treat the consequences in thin patients, as in the case of congenital lipodystrophy. For example.
Myalept contains metreleptin in its composition and can be purchased in the United States with a prescription, in the form of a subcutaneous injection, similar to insulin pens.
- Myalept is indicated as a substitute treatment in patients with complications from lack of leptin.
- As in cases of acquired or congenital generalized lipodystrophy.
How you use Myalept varies depending on the patient’s weight and gender, with general guidelines including:
Therefore, the dose of Myalept should always be indicated by an endocrinologist. Myalept is given by injection under the skin, so it is important to receive advice from a doctor or nurse on how to use the injection.
The main side effects of Myalept include headache, weight loss, abdominal pain and lower blood sugar levels, which can lead to fatigue, dizziness and cold sweats.
Myalept is contraindicated in patients with obesity not associated with congenital leptin deficiency or hypersensitivity to metreleptin.